Partial enteral nutrition induces clinical and endoscopic remission in active pediatric Crohn's disease: results of a prospective cohort study.
Children
Crohn’s disease
Exclusive enteral nutrition
Partial enteral nutrition
Journal
European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
15
07
2019
accepted:
29
10
2019
revised:
03
10
2019
pubmed:
30
11
2019
medline:
2
12
2020
entrez:
30
11
2019
Statut:
ppublish
Résumé
The aim of this study was to evaluate rates of clinical remission, endoscopic remission, and mucosal healing after a 6-week treatment period with partial enteral nutrition (PEN) and to compare them to those obtained by standard exclusive enteral nutrition (EEN) treatment in children with active Crohn's disease (CD). Twenty-five patients with active CD (median age 13.6 years, range 3.6-18.0) were recruited to either PEN (n = 12) or EEN (n = 13) treatment groups. The PEN group received 75% of their dietary needs from a polymeric formula plus one meal per day from an anti-inflammatory diet (AID). Patients were assessed at weeks 0, 1, 3, and 6 using clinical and laboratory parameters. Endoscopic assessment was performed at induction and week 6. On intention to treat analysis, clinical remission (Pediatric CD Activity Index < 10) was achieved in 69.2% and 75.0% of EEN and PEN patients, respectively (p = 0.999). The endoscopic remission (Simple Endoscopic Score for CD (SES-CD) ≤ 2) rates were 45.5% in both groups, while mucosal healing rates (SES-CD = 0) were 45.5% with EEN and 27.3% with PEN (p = 0.659).Conclusion: The results of our prospective pilot study suggest that PEN, allowing one meal from AID, could be as effective as EEN in inducing clinical and endoscopic remission in children with active CD. However, larger randomized controlled studies are warranted to confirm our findings.Trial registration: This clinical trial was registered under the number ClinicalTrials.govidentifier: NCT03176875.What is Known:• Exclusive enteral nutrition is a first-line treatment in active pediatric Crohn's disease; however, patients often find it difficult to adhere to.• Exclusive enteral nutrition is more effective than corticosteroids in achieving mucosal healing.What is New:• This is the first prospective study on partial enteral nutrition in active pediatric Crohn's disease, evaluating not only clinical, but also endoscopic remission.• A novel approach of partial enteral nutrition that allows one meal per day from an anti-inflammatory diet was as effective as exclusive enteral nutrition in inducing clinical and endoscopic remission in active Crohn's disease.
Identifiants
pubmed: 31781933
doi: 10.1007/s00431-019-03520-7
pii: 10.1007/s00431-019-03520-7
doi:
Banques de données
ClinicalTrials.gov
['NCT03176875']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
431-438Subventions
Organisme : Javna Agencija za Raziskovalno Dejavnost RS
ID : P3-0395
Références
Inflamm Bowel Dis. 2015 Aug;21(8):1786-93
pubmed: 25970545
Aliment Pharmacol Ther. 2017 Oct;46(7):645-656
pubmed: 28815649
Food Funct. 2016 Nov 9;7(11):4492-4505
pubmed: 27783083
Inflamm Bowel Dis. 2009 Sep;15(9):1295-301
pubmed: 19340881
Aliment Pharmacol Ther. 2007 Sep 15;26(6):795-806
pubmed: 17767463
Gut. 2015 Mar;64(3):438-46
pubmed: 24821616
Aliment Pharmacol Ther. 2009 Sep 1;30(5):501-7
pubmed: 19549288
J Pediatr Gastroenterol Nutr. 2018 Sep;67(3):414-430
pubmed: 30130311
J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):8-15
pubmed: 10896064
Curr Gastroenterol Rep. 2017 May;19(5):22
pubmed: 28397133
J Pediatr Gastroenterol Nutr. 2018 Apr;66(4):687-708
pubmed: 29570147
J Med Food. 2019 Feb;22(2):162-169
pubmed: 30632875
Inflamm Bowel Dis. 2013 Jun;19(7):1374-8
pubmed: 23567777
Gut. 2018 Sep;67(9):1726-1738
pubmed: 29777041
Inflamm Bowel Dis. 2013 May;19(6):1285-94
pubmed: 23567784
Gut. 2017 Aug;66(8):1414-1427
pubmed: 28325746
J Crohns Colitis. 2014 Oct;8(10):1179-207
pubmed: 24909831
Inflamm Bowel Dis. 2014 Aug;20(8):1353-60
pubmed: 24983973
Nature. 2012 Jul 5;487(7405):104-8
pubmed: 22722865
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):e22-e29
pubmed: 29543696
Gastroenterology. 2019 Aug;157(2):440-450.e8
pubmed: 31170412
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):254-260
pubmed: 27050050
Clin Gastroenterol Hepatol. 2006 Jun;4(6):744-53
pubmed: 16682258
Gut. 2014 Jan;63(1):116-24
pubmed: 23598352
Clin Nutr. 2005 Oct;24(5):775-9
pubmed: 15904998
Gastroenterology. 2010 Feb;138(2):463-8; quiz e10-1
pubmed: 19818785
Dig Liver Dis. 2006 Jun;38(6):381-7
pubmed: 16301010
J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):795-806
pubmed: 24231644
Aliment Pharmacol Ther. 2014 Jun;39(12):1398-407
pubmed: 24779671
Gut. 2006 Mar;55(3):356-61
pubmed: 16162683
J Gastroenterol. 2014 Apr;49(4):638-45
pubmed: 23636735